Liane te Boome

Refinement of the Definition of Permissible HLA-DPB1 Mismatches with Predicted Indirectly ReCognizable HLA-DPB1 Epitopes

Kirsten A. Thus, Mieke T.A. Ruizendaal, Talitha A. de Hoop et al. · Biology of Blood and Marrow Transplantation · 2014 · 37 citations · Full text

Histocompatibility, Hla, Hla Immunogenetics +25

Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT

Grzegorz Basak, W Wiktor-Jędrzejczak, Myriam Labopin et al. · American Journal of Transplantation · 2015 · 27 citations · Full text

The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study

S. van Dorp, Henrike K. Resemann, Liane te Boome et al. · Haematologica · 2011 · 18 citations · Full text

Frequent mutated <i>B2M</i>, <i>EZH2</i>, <i>IRF8</i>, and <i>TNFRSF14</i> in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype

Ruben A. L. de Groen, Ronald van Eijk, Stefan Böehringer et al. · Blood Advances · 2021 · 17 citations · Full text

Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib

Lotte van der Wagen, Liane te Boome, Marleen Schiffler et al. · Bone Marrow Transplantation · 2018 · 16 citations

Transplantation, Systemic Scleroderma, Pathology +7